| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.57B | 14.88B | 14.46B | 14.04B | 13.32B | 11.60B |
| Gross Profit | 2.40B | 2.46B | 2.36B | 1.99B | 1.38B | 600.00M |
| EBITDA | 4.30B | 4.00B | 4.32B | 3.13B | 2.46B | 2.49B |
| Net Income | 1.79B | 1.83B | 1.74B | 2.09B | 1.22B | 673.00M |
Balance Sheet | ||||||
| Total Assets | 24.40B | 26.62B | 25.25B | 23.00B | 21.18B | 20.15B |
| Cash, Cash Equivalents and Short-Term Investments | 2.25B | 2.39B | 2.16B | 1.96B | 1.97B | 1.72B |
| Total Debt | 6.72B | 6.36B | 7.06B | 7.36B | 7.86B | 8.66B |
| Total Liabilities | 10.20B | 10.90B | 11.59B | 11.22B | 11.72B | 12.05B |
| Stockholders Equity | 12.92B | 14.33B | 12.43B | 10.72B | 8.55B | 7.31B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 955.00M | 761.00M | -222.00M | 879.00M | 538.00M |
| Operating Cash Flow | 0.00 | 2.88B | 3.63B | 2.46B | 2.33B | 1.58B |
| Investing Cash Flow | 0.00 | -1.65B | -2.95B | -1.75B | -1.10B | -975.00M |
| Financing Cash Flow | 0.00 | -1.01B | -463.00M | -715.00M | -986.00M | -936.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥14.49B | 8.51 | ― | 0.26% | 2.92% | 5.59% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥313.65B | 13.49 | ― | 1.61% | 1.51% | 14.84% | |
60 Neutral | ¥42.42B | 11.08 | ― | 2.17% | 4.27% | 33.45% | |
58 Neutral | ¥220.46B | 7.11 | 12.70% | 1.68% | 6.91% | 58.68% | |
54 Neutral | ¥19.31B | 13.17 | ― | 0.81% | 5.49% | 29.14% | |
50 Neutral | ¥18.43B | 16.20 | ― | 1.33% | 11.16% | -16.05% |